Development of a companion diagnostic assay for detection of ADAM8-positive cancers
Ended Project Grant Awarded Last action
- Award ID
- R43CA239942
- Recipient
-
Adecto Pharmaceuticals, Inc. UEI DAR5SR7BVBB6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA239942?
R43CA239942 was awarded to Adecto Pharmaceuticals, Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2019.
How much is award R43CA239942 worth?
$300,000 has been obligated on R43CA239942.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award